ICHI GmbH provides reimbursement-focused consulting for medical devices and pharmaceuticals, including health technology assessment (HTA), evidence evaluation, and the design and implementation of clinical studies. Services also include reimbursement strategy development such as economic modelling, organisation of hearings, mediation services and DRG-related support.
AI-generated
Offering
Products & services
Industry:Management ConsultingMedical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Reimbursement solutions, reimbursement strategy, economic modelling, organisation of hearings, mediation, and support to secure payment by health insurers.
Health Technology Assessment (HTA)
Health Technology Assessment, evidence appraisal, identification of evidence gaps, as well as support in defining requirements for successful product adoption.
Clinical studies and research
Design and implementation of clinical studies, commissioning of research, and minimisation of processes for presenting and validating clinical benefit.
Mandatory benefits and compensation
Advising on mandatory benefits and compensation in connection with reimbursement for medical services and products.
Supplementary insurance
Advising on supplementary insurance in the context of reimbursement, market access, and reimbursement issues.
Knowledge
No knowledge articles yet
Once ICHI GmbH has claimed this profile, we'll publish editorial articles and case studies here together.